Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)

CompletedOBSERVATIONAL
Enrollment

289

Participants

Timeline

Start Date

November 15, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
the Maintenance Phase After Kidney Transplantation
Interventions
DRUG

Graceptor®

oral

Trial Locations (30)

Unknown

Site JP00010, Numakunai

Site JP00001, Aichi

Site JP00015, Chiba

Site JP00003, Ehime

Site JP00029, Fukuoka

Site JP00009, Fukushima

Site JP00017, Gifu

Site JP00002, Hiroshima

Site JP00005, Hokkaido

Site JP00024, Hyōgo

Site JP00012, Ibaraki

Site JP00020, Ishikawa

Site JP00026, Kagawa

Site JP00030, Kagoshima

Site JP00014, Kanagawa

Site JP00027, Kochi

Site JP00028, Kumamoto

Site JP00008, Kyoto

Site JP00019, Mie

Site JP00011, Miyagi

Site JP00006, Nagasaki

Site JP00023, Nara

Site JP00013, Niigata

Site JP00025, Okayama

Site JP00022, Osaka

Site JP00016, Saitama

Site JP00018, Shizuoka

Site JP00007, Tokyo

Site JP00021, Wakayama

Site JP00004, Yamagata

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY